BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24103457)

  • 21. Four-factor prothrombin complex concentrate is associated with improved survival in trauma-related hemorrhage: A nationwide propensity-matched analysis.
    Zeeshan M; Hamidi M; Feinstein AJ; Gries L; Jehan F; Sakran J; Northcutt A; OʼKeeffe T; Kulvatunyou N; Joseph B
    J Trauma Acute Care Surg; 2019 Aug; 87(2):274-281. PubMed ID: 30889141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted fibrinogen concentrate use in severe traumatic haemorrhage.
    Seebold JA; Campbell D; Wake E; Walters K; Ho D; Chan E; Bulmer AC; Wullschleger M; Winearls J
    Crit Care Resusc; 2019 Sep; 21(3):171-178. PubMed ID: 31462204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early coagulopathy at hospital admission predicts initial or delayed fibrinogen deficit in severe trauma patients.
    Deras P; Villiet M; Manzanera J; Latry P; Schved JF; Capdevila X; Charbit J
    J Trauma Acute Care Surg; 2014 Sep; 77(3):433-40. PubMed ID: 25159247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of prothrombin complex concentrate as an adjunct to fresh frozen plasma shortens time to craniotomy in traumatic brain injury patients.
    Joseph B; Pandit V; Khalil M; Kulvatunyou N; Aziz H; Tang A; OʼKeeffe T; Hays D; Gries L; Lemole M; Friese RS; Rhee P
    Neurosurgery; 2015 May; 76(5):601-7; discussion 607. PubMed ID: 25886249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of prehospital administration of fibrinogen concentrate in trauma patients bleeding or presumed to bleed (FIinTIC): A multicentre, double-blind, placebo-controlled, randomised pilot study.
    Ziegler B; Bachler M; Haberfellner H; Niederwanger C; Innerhofer P; Hell T; Kaufmann M; Maegele M; Martinowitz U; Nebl C; Oswald E; Schöchl H; Schenk B; Thaler M; Treichl B; Voelckel W; Zykova I; Wimmer C; Fries D;
    Eur J Anaesthesiol; 2021 Apr; 38(4):348-357. PubMed ID: 33109923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of 4-Factor Prothrombin Complex Concentrate in Trauma and Acute-Care Surgical Patients.
    Sellers W; Bendas C; Toy F; Klock B; Kerestes J; Young A; Badger C; Jensen J; Becker N
    J Am Osteopath Assoc; 2018 Dec; 118(12):789-797. PubMed ID: 30476990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immediate Higher-Dose Prothrombin Complex Concentrate Without Fresh Frozen Plasma or Fibrinogen Concentrate for Significant Coagulopathic Cardiac Surgical Field Bleeding.
    Pruthi P; Culliver C; Emel H; Georghie S; Benson MJ; Matalanis G; Yanase F; Bellomo R
    Heart Lung Circ; 2022 Sep; 31(9):1300-1306. PubMed ID: 35843859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experience with prothrombin complex for the emergent reversal of anticoagulation in rural geriatric trauma patients.
    Quick JA; Bartels AN; Coughenour JP; Barnes SL
    Surgery; 2012 Oct; 152(4):722-6; discussion 726-8. PubMed ID: 22943840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery.
    Solomon C; Pichlmaier U; Schoechl H; Hagl C; Raymondos K; Scheinichen D; Koppert W; Rahe-Meyer N
    Br J Anaesth; 2010 May; 104(5):555-62. PubMed ID: 20348140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of intraoperative factor concentrates on blood product transfusions during orthotopic liver transplantation.
    Colavecchia AC; Cohen DA; Harris JE; Thomas JM; Lindberg S; Leveque C; Salazar E
    Transfusion; 2017 Dec; 57(12):3026-3034. PubMed ID: 28960322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prothrombin complex concentrate vs fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma model.
    Dickneite G; Pragst I
    Br J Anaesth; 2009 Mar; 102(3):345-54. PubMed ID: 19168856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma.
    Innerhofer P; Westermann I; Tauber H; Breitkopf R; Fries D; Kastenberger T; El Attal R; Strasak A; Mittermayr M
    Injury; 2013 Feb; 44(2):209-16. PubMed ID: 23000050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients.
    Solomon C; Cadamuro J; Ziegler B; Schöchl H; Varvenne M; Sørensen B; Hochleitner G; Rahe-Meyer N
    Transfusion; 2011 Aug; 51(8):1695-706. PubMed ID: 21352237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Observational study of fibrinogen concentrate in massive hemorrhage: evaluation of a multicenter register.
    Weiss G; Lison S; Glaser M; Herberger S; Johanning K; Strasser T; Huber T; Spannagl M; Heindl B
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):727-34. PubMed ID: 22024795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perioperative dilutional coagulopathy treated with fresh frozen plasma and fibrinogen concentrate: a prospective randomized intervention trial.
    Lancé MD; Ninivaggi M; Schols SE; Feijge MA; Oehrl SK; Kuiper GJ; Nikiforou M; Marcus MA; Hamulyak K; van Pampus EC; ten Cate H; Heemskerk JW
    Vox Sang; 2012 Jul; 103(1):25-34. PubMed ID: 22211833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and Safety of Early Administration of 4-Factor Prothrombin Complex Concentrate in Patients With Trauma at Risk of Massive Transfusion: The PROCOAG Randomized Clinical Trial.
    Bouzat P; Charbit J; Abback PS; Huet-Garrigue D; Delhaye N; Leone M; Marcotte G; David JS; Levrat A; Asehnoune K; Pottecher J; Duranteau J; Courvalin E; Adolle A; Sourd D; Bosson JL; Riou B; Gauss T; Payen JF;
    JAMA; 2023 Apr; 329(16):1367-1375. PubMed ID: 36942533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose fibrinogen versus a clinically recommended dose of fresh frozen plasma for reversal of dilutional coagulopathy in an in vitro model of severe hemodilution.
    Rosenthal C; Rau J; Volk T; Sander M; Ziemer S; Von Heymann C
    Minerva Anestesiol; 2014 Aug; 80(8):894-903. PubMed ID: 24398441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro comparative study of hemostatic components in warfarin-treated and fibrinogen-deficient plasma.
    Rumph B; Bolliger D; Narang N; Molinaro RJ; Levy JH; Szlam F; Tanaka KA
    J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):408-12. PubMed ID: 19819728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thromboelastometric (ROTEM) findings in patients suffering from isolated severe traumatic brain injury.
    Schöchl H; Solomon C; Traintinger S; Nienaber U; Tacacs-Tolnai A; Windhofer C; Bahrami S; Voelckel W
    J Neurotrauma; 2011 Oct; 28(10):2033-41. PubMed ID: 21942848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro effects of different sources of fibrinogen supplementation on clot initiation and stability in a model of dilutional coagulopathy.
    Schäfer N; Driessen A; Bauerfeind U; Fröhlich M; Ofir J; Stürmer EK; Maegele M
    Transfus Med; 2016 Oct; 26(5):373-380. PubMed ID: 27506588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.